title: Reply to “Response to “CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype”. Haematologica 2012;97(7):1110-1114.
authors: Teresa
authors: T
authors: Paíno
authors: Bruno
authors: B
authors: Paiva
authors: Jesús
authors: J
authors: San Miguel
mesh_terms: D000818:Animals; D018951:Antigens, CD20 / Q000235:genetics*; D014408:Biomarkers, Tumor / Q000235:genetics*; D006801:Humans; D009101:Multiple Myeloma / Q000378:metabolism*; D014411:Neoplastic Stem Cells / Q000378:metabolism*
chemical_list: D018951:Antigens, CD20; D014408:Biomarkers, Tumor
references: Leukemia. 2013 Mar;27(3):680-5
references: 22902364
references: Leukemia. 2011 Apr;25(4):697-706
references: 21252988
references: Blood. 2005 Oct 1;106(7):2276-9
references: 15961515
references: Haematologica. 2012 Jul;97(7):1110-4
references: 22315496
references: Blood. 2004 Mar 15;103(6):2332-6
references: 14630803
references: Leukemia. 2012 Sep;26(9):2135-41
references: 22430638
references: Haematologica. 2013 Jan;98(1):e11
references: 23277593
references: Haematologica. 2011 Sep;96(9):1246-8
references: 21880640
references: J Clin Oncol. 2005 Aug 20;23(24):5668-74
references: 16110026
references: Haematologica. 2010 Jun;95(6):1016-20
references: 20081059
references: Cell. 2011 Aug 19;146(4):633-44
references: 21854987
references: Blood. 1994 Feb 1;83(3):724-36
references: 7507731